As of Jan 13
| -0.04 / -0.91%|
The 5 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 3.00, with a high estimate of 3.50 and a low estimate of 1.50. The median estimate represents a -31.19% decrease from the last price of 4.36.
The current consensus among 5 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.